Inactivating Gsα mutations lead to multihormone resistance, including end-organ resistance to the parathyroid hormone (PTH), termed pseudohypoparathyroidism (PHP) (4–7). The gene discussed is PTH; the disease is pseudohypoparathyroidism type 1A.